Bronchogen
Bronchogen (Ala-Glu-Asp-Leu)
Khavinson's four-amino-acid lung bioregulator
Bronchogen is a synthetic tetrapeptide bioregulator developed by Vladimir Khavinson's group for supporting bronchial and lung tissue health.
Admin routes
Oral (capsule)
Popularity
Niche
Side effects
Generally mild
AU vendors
0 rated
✓Key benefits
📈What to expect
Possible improvement in respiratory comfort (Russian reports)
Benefits reported to persist for several months after a course
Based on community reports and published research. Individual results vary significantly.
💊Dosing protocols
Respiratory support (Russian protocol)
10 mg (1-2 capsules)
1-2 times daily
10-20 day courses, repeated 2-3 times per year
Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.
Research status|Used in Russian clinical practice; limited Western peer review
Overview
Bronchogen is part of the Khavinson peptide bioregulator series developed at the Saint Petersburg Institute of Bioregulation and Gerontology. It is a synthetic version of a short peptide sequence identified in bronchial tissue extracts. In Russian clinical practice, it is used to support respiratory health, particularly in patients with chronic bronchitis, COPD, and age-related decline in lung function. Like other Khavinson bioregulators, the evidence base consists primarily of Russian clinical studies that have not been replicated in Western randomised controlled trials.
⚙️How it works
According to Khavinson's peptide bioregulation theory, short peptides like bronchogen interact with DNA regulatory regions in tissue-specific cells, influencing gene expression related to tissue maintenance and repair. For bronchogen specifically, this is proposed to restore protein synthesis in bronchial epithelial cells, normalising mucus production, ciliary function, and local immune defence in the airways.
⚡Side effects
📅Research history
Bronchogen developed at the Saint Petersburg Institute of Bioregulation
References
- [1]Khavinson VK. 'Peptide bioregulators: a new class of geroprotectors.' 2006.
Frequently asked questions
Related peptides
Community experiences
Share your experience with Bronchogen. Effects, side effects, protocol details - help others make informed decisions.
No community reviews yet. Be the first to share your experience with Bronchogen.
Need to calculate your dose?
Use our free reconstitution calculator to work out syringe units for Bronchogen.
Open CalculatorFound this useful?
Share this guide
Disclaimer: This guide is for educational and informational purposes only. It is not medical advice. The dosing protocols listed are sourced from published research and community reports and do not constitute a recommendation. Always consult a qualified healthcare professional before using any peptide. Australian regulations classify many peptides as Schedule 4 (prescription-only) substances. Check current TGA guidelines before purchasing.